论文信息 - Azacitidine (AZA) with Nivolumab (Nivo), and AZA with Nivo + Ipilimumab (Ipi) in Relapsed/Refractory Acute Myeloid Leukemia: A Non-Randomized, Prospective, Phase 2 Study - 字舞流文

Azacitidine (AZA) with Nivolumab (Nivo), and AZA with Nivo + Ipilimumab (Ipi) in Relapsed/Refractory Acute Myeloid Leukemia: A Non-Randomized, Prospective, Phase 2 Study

P. Sharma | M. Konopleva | Z. Estrov | J. Allison | H. Kantarjian | G. Garcia-Manero | J. Cortes | T. Kadia | F. Ravandi | Koichi Takahashi | E. Jabbour | N. Daver | C. Dinardo | S. Pierce | S. Kornblau | J. Ning | N. Pemmaraju | S. Basu | H. Abbas | L. Masarová | K. Sasaki | M. Alfayez | W. Flores